Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) - Total Liabilities

Latest as of March 2026: ₫870.62 Billion VND ≈ $33.08 Million USD

Based on the latest financial reports, Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has total liabilities worth ₫870.62 Billion VND (≈ $33.08 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Binh Dinh Pharmaceutical and Medical Equipment JSC - Total Liabilities Trend (2020–2025)

This chart illustrates how Binh Dinh Pharmaceutical and Medical Equipment JSC's total liabilities have evolved over time, based on quarterly financial data. See Binh Dinh Pharmaceutical and Medical Equ (DBD) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Binh Dinh Pharmaceutical and Medical Equipment JSC Competitors by Total Liabilities

The table below lists competitors of Binh Dinh Pharmaceutical and Medical Equipment JSC ranked by their total liabilities.

Company Country Total Liabilities
JCY International Bhd
KLSE:5161
Malaysia RM113.43 Million
Indonesia Prima Property Tbk
JK:OMRE
Indonesia Rp723.98 Billion
Taskus Inc
NASDAQ:TASK
USA $706.46 Million
Ditas Dogan Yedek Parca Imalat ve Teknik AS
IS:DITAS
Turkey TL2.39 Billion
Dynamix Corporation
NASDAQ:ETHM
USA $17.60 Million
Dynamix Corp
NASDAQ:DYNC
USA $17.60 Million
Wah Hong Industrial
TWO:8240
Taiwan NT$2.70 Billion
Parsan Makina Parcalari Sanayi AS
IS:PARSN
Turkey TL8.05 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down Binh Dinh Pharmaceutical and Medical Equipment JSC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Binh Dinh Pharmaceutical and Medical Equ (DBD) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.99 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.48 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Binh Dinh Pharmaceutical and Medical Equipment JSC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)

The table below shows the annual total liabilities of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025.

Year Total Liabilities Change
2025-12-31 ₫862.89 Billion
≈ $32.78 Million
+43.08%
2024-12-31 ₫603.07 Billion
≈ $22.91 Million
+8.45%
2023-12-31 ₫556.07 Billion
≈ $21.13 Million
+2.86%
2022-12-31 ₫540.58 Billion
≈ $20.54 Million
+29.03%
2021-12-31 ₫418.97 Billion
≈ $15.92 Million
-6.64%
2020-12-31 ₫448.78 Billion
≈ $17.05 Million
--

About Binh Dinh Pharmaceutical and Medical Equipment JSC

VN:DBD Vietnam Drug Manufacturers - Specialty & Generic
Market Cap
$179.32 Million
₫4.72 Trillion VND
Market Cap Rank
#17046 Global
#106 in Vietnam
Share Price
₫49950.00
Change (1 day)
+0.00%
52-Week Range
₫48050.00 - ₫56700.00
All Time High
₫62000.00
About

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous … Read more